Most Taiwanese firms are small- and medium-sized enterprises that would find it difficult to compete with major pharmaceuticals manufacturers. But we can go the route of small firms, developing products to a certain stage, then seeking alliances with big international firms, or granting them licenses that let them manufacture the products and take them to market. Either approach is feasible.
國內大多是中小企業，難與大藥廠競爭，但從創新發明的角度看，我們可以走小廠路線，研發到一個地步，接下來就尋求與國際大廠聯盟，或是授權他們量產、開拓市場，都是可行的模式。